Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Waldenström macroglobulinemia, Richter syndrome, and B-cell chronic lymphocytic leukemia to the conditions section, and updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays revision number v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no other changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange Detected- The page revision was updated from v3.4.0 to v3.4.1 (added v3.4.1 and removed v3.4.0).SummaryDifference0.1%

- Check73 days agoChange DetectedUI updates include adding Show glossary and Hide glossary controls, and introducing new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' in Study Record Dates, while removing older labels like 'Last Update Submitted that met QC Criteria' and 'Last Update Posted (Estimated)'. Footer/meta updates include adding 'No FEAR Act Data' and 'Revision: v3.4.0', while removing 'No FEAR Act data' and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 at the bottom of the page.SummaryDifference0.0%

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.